Olugbenga Akinkugbe, Luca Marchetto, Isaac Martin, Shin Hann Chia
{"title":"儿科危重症后慢性肾病发病率的系统回顾和元分析。","authors":"Olugbenga Akinkugbe, Luca Marchetto, Isaac Martin, Shin Hann Chia","doi":"10.1097/CCE.0000000000001129","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Survivors of pediatric critical illnesses are at risk of significant long-term organ sequelae. Chronic kidney disease (CKD) is a complication of critical illness (and ICU interventions) associated with growth impairment, cardiovascular disease, and early death. Our objective was to synthesize the evidence on the incidence of CKD among survivors of pediatric critical illness.</p><p><strong>Data sources: </strong>MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature, and Cochrane Register of Controlled Trials from inception to February 2024.</p><p><strong>Study selection: </strong>Observational studies reporting the incidence of de novo CKD among survivors of pediatric critical illness.</p><p><strong>Data extraction: </strong>Two reviewers independently extracted data on study design, setting, population, demographics, diagnostic criteria, and outcome.</p><p><strong>Data synthesis: </strong>Meta-analysis was used to describe the incidence of CKD among survivors, risk of bias (RoB) assessed using the Joanna Briggs Institute Tool, and strength and reliability of evidence assessed with GRADE (Grading of Recommendations, Assessment, Development, and Evaluations). CKD was quantified as an estimated glomerular filtration rate (eGFR) less than 90 mL/min/1.73 m2 (outcome 1), eGFR less than 60 mL/min/1.73 m2 (outcome 2), and end-stage renal disease (ESRD) as eGFR less than 15 mL/min per 1.73 m2 (outcome 3). Twelve studies (3642 patients) met selection criteria and reported at least one measure of CKD. The median duration of follow-up was 2, 3.6, and 5 years, respectively, for outcomes 1, 2, and 3. For each threshold, the pooled estimate of CKD incidence was 24% (95% CI, 16-32%) for eGFR less than 90, 14% (95% CI, 6-23%) less than 60, and 4% (95% CI, 0-7%) for ESRD. The overall quality assessment indicated a moderate RoB.</p><p><strong>Conclusions: </strong>Among a heterogenous population of pediatric critical illness survivors, an important minority of survivors developed CKD or ESRD. This study highlights the importance of diagnostic criteria for reporting, a greater focus on postcritical care surveillance and follow-up to identify those with CKD. Further study would facilitate the delineation of high-risk groups and strategies for improved outcomes.</p>","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":"6 8","pages":"e1129"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Systematic Review and Meta-Analysis of the Incidence of Chronic Kidney Disease After Pediatric Critical Illness.\",\"authors\":\"Olugbenga Akinkugbe, Luca Marchetto, Isaac Martin, Shin Hann Chia\",\"doi\":\"10.1097/CCE.0000000000001129\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Survivors of pediatric critical illnesses are at risk of significant long-term organ sequelae. Chronic kidney disease (CKD) is a complication of critical illness (and ICU interventions) associated with growth impairment, cardiovascular disease, and early death. Our objective was to synthesize the evidence on the incidence of CKD among survivors of pediatric critical illness.</p><p><strong>Data sources: </strong>MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature, and Cochrane Register of Controlled Trials from inception to February 2024.</p><p><strong>Study selection: </strong>Observational studies reporting the incidence of de novo CKD among survivors of pediatric critical illness.</p><p><strong>Data extraction: </strong>Two reviewers independently extracted data on study design, setting, population, demographics, diagnostic criteria, and outcome.</p><p><strong>Data synthesis: </strong>Meta-analysis was used to describe the incidence of CKD among survivors, risk of bias (RoB) assessed using the Joanna Briggs Institute Tool, and strength and reliability of evidence assessed with GRADE (Grading of Recommendations, Assessment, Development, and Evaluations). CKD was quantified as an estimated glomerular filtration rate (eGFR) less than 90 mL/min/1.73 m2 (outcome 1), eGFR less than 60 mL/min/1.73 m2 (outcome 2), and end-stage renal disease (ESRD) as eGFR less than 15 mL/min per 1.73 m2 (outcome 3). Twelve studies (3642 patients) met selection criteria and reported at least one measure of CKD. The median duration of follow-up was 2, 3.6, and 5 years, respectively, for outcomes 1, 2, and 3. For each threshold, the pooled estimate of CKD incidence was 24% (95% CI, 16-32%) for eGFR less than 90, 14% (95% CI, 6-23%) less than 60, and 4% (95% CI, 0-7%) for ESRD. The overall quality assessment indicated a moderate RoB.</p><p><strong>Conclusions: </strong>Among a heterogenous population of pediatric critical illness survivors, an important minority of survivors developed CKD or ESRD. This study highlights the importance of diagnostic criteria for reporting, a greater focus on postcritical care surveillance and follow-up to identify those with CKD. Further study would facilitate the delineation of high-risk groups and strategies for improved outcomes.</p>\",\"PeriodicalId\":93957,\"journal\":{\"name\":\"Critical care explorations\",\"volume\":\"6 8\",\"pages\":\"e1129\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Critical care explorations\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/CCE.0000000000001129\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/8/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical care explorations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/CCE.0000000000001129","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
目的:儿科危重病幸存者有可能出现严重的长期器官后遗症。慢性肾脏疾病(CKD)是危重病(和重症监护室干预)的并发症,与生长障碍、心血管疾病和早死有关。我们的目标是综合儿科危重症幸存者中慢性肾脏病发病率的证据:MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature, and Cochrane Register of Controlled Trials from inception to February 2024.研究选择:报告儿科危重症幸存者新发慢性肾脏病发病率的观察性研究:两名审稿人独立提取了有关研究设计、环境、人群、人口统计学、诊断标准和结果的数据:数据综合:采用荟萃分析法描述幸存者中CKD的发生率,采用乔安娜-布里格斯研究所工具评估偏倚风险(RoB),采用GRADE(建议、评估、发展和评价分级)评估证据的强度和可靠性。慢性肾功能衰竭的量化标准为估计肾小球滤过率(eGFR)小于 90 毫升/分钟/1.73 平方米(结果 1)、eGFR 小于 60 毫升/分钟/1.73 平方米(结果 2)、终末期肾病(ESRD)为 eGFR 小于 15 毫升/分钟/1.73 平方米(结果 3)。有 12 项研究(3642 名患者)符合筛选标准,并报告了至少一项 CKD 指标。结果 1、2 和 3 的中位随访时间分别为 2 年、3.6 年和 5 年。对于每个阈值,eGFR 小于 90 的 CKD 发生率的汇总估计值为 24% (95% CI, 16-32%),小于 60 的为 14% (95% CI, 6-23%),ESRD 为 4% (95% CI, 0-7%)。总体质量评估结果为中度RoB:结论:在儿科危重症幸存者的不同人群中,有相当一部分幸存者出现了 CKD 或 ESRD。这项研究强调了报告诊断标准的重要性,以及更加重视危重症护理后监测和随访以识别出患有 CKD 的幸存者。进一步的研究将有助于确定高危人群和改善预后的策略。
Systematic Review and Meta-Analysis of the Incidence of Chronic Kidney Disease After Pediatric Critical Illness.
Objective: Survivors of pediatric critical illnesses are at risk of significant long-term organ sequelae. Chronic kidney disease (CKD) is a complication of critical illness (and ICU interventions) associated with growth impairment, cardiovascular disease, and early death. Our objective was to synthesize the evidence on the incidence of CKD among survivors of pediatric critical illness.
Data sources: MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature, and Cochrane Register of Controlled Trials from inception to February 2024.
Study selection: Observational studies reporting the incidence of de novo CKD among survivors of pediatric critical illness.
Data extraction: Two reviewers independently extracted data on study design, setting, population, demographics, diagnostic criteria, and outcome.
Data synthesis: Meta-analysis was used to describe the incidence of CKD among survivors, risk of bias (RoB) assessed using the Joanna Briggs Institute Tool, and strength and reliability of evidence assessed with GRADE (Grading of Recommendations, Assessment, Development, and Evaluations). CKD was quantified as an estimated glomerular filtration rate (eGFR) less than 90 mL/min/1.73 m2 (outcome 1), eGFR less than 60 mL/min/1.73 m2 (outcome 2), and end-stage renal disease (ESRD) as eGFR less than 15 mL/min per 1.73 m2 (outcome 3). Twelve studies (3642 patients) met selection criteria and reported at least one measure of CKD. The median duration of follow-up was 2, 3.6, and 5 years, respectively, for outcomes 1, 2, and 3. For each threshold, the pooled estimate of CKD incidence was 24% (95% CI, 16-32%) for eGFR less than 90, 14% (95% CI, 6-23%) less than 60, and 4% (95% CI, 0-7%) for ESRD. The overall quality assessment indicated a moderate RoB.
Conclusions: Among a heterogenous population of pediatric critical illness survivors, an important minority of survivors developed CKD or ESRD. This study highlights the importance of diagnostic criteria for reporting, a greater focus on postcritical care surveillance and follow-up to identify those with CKD. Further study would facilitate the delineation of high-risk groups and strategies for improved outcomes.